12 Aug 2022 , 08:15 AM
Net profit of Gufic BioSciences declined 32.55% to Rs 21.05 crore in the quarter ended June 2022 as against Rs 31.21 crore during the previous quarter ended June 2021. Sales declined 34.09% to Rs 165.28 crore in the quarter ended June 2022 as against Rs 250.76 crore during the previous quarter ended June 2021.
| Particulars | Quarter Ended | ||
| ? | Jun. 2022 | Jun. 2021 | % Var. |
| Sales | 165.28 | 250.76 | -34 |
| OPM % | 20.08 | 18.20 | – |
| PBDT | 32.65 | 45.67 | -29 |
| PBT | 28.28 | 41.54 | -32 |
| NP | 21.05 | 31.21 | -33 |
Powered by Capital Market – Live News
Related Tags
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
